Cargando…

Vitamin D associates with improved quality of life in participants with irritable bowel syndrome: outcomes from a pilot trial

BACKGROUND: Vitamin D deficiency has been associated or implicated with the pathophysiology of the gastrointestinal conditions inflammatory bowel disease and colorectal cancer, as well as with depression. No trials or epidemiology studies to date have investigated a link with irritable bowel syndrom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tazzyman, Simon, Richards, Nicholas, Trueman, Andrew R, Evans, Amy L, Grant, Vicky A, Garaiova, Iveta, Plummer, Sue F, Williams, Elizabeth A, Corfe, Bernard M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2015
Materias:	Irritable Bowel Syndrome
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691664/ https://www.ncbi.nlm.nih.gov/pubmed/26719813 http://dx.doi.org/10.1136/bmjgast-2015-000052

Ejemplares similares

A Swedish national adoption study of risk of irritable bowel syndrome (IBS)
por: Waehrens, Rasmus, et al.
Publicado: (2017)

Faecal incontinence—the hidden scourge of irritable bowel syndrome: a cross-sectional study
por: Atarodi, Sima, et al.
Publicado: (2015)

Efficacy of individualised diets in patients with irritable bowel syndrome: a randomised controlled trial
por: Ali, Ather, et al.
Publicado: (2017)

Two microbiota subtypes identified in irritable bowel syndrome with distinct responses to the low FODMAP diet
por: Vervier, Kevin, et al.
Publicado: (2022)

Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double‐blind, placebo‐controlled trials
por: Schoenfeld, P., et al.
Publicado: (2014)

Does Fibre-fix provided to people with irritable bowel syndrome who are consuming a low FODMAP diet improve their gut health, gut microbiome, sleep and mental health? A double-blinded, randomised controlled trial
por: Yan, Ran, et al.
Publicado: (2020)

Effects of baseline abdominal pain and bloating on response to lubiprostone in patients with irritable bowel syndrome with constipation
por: Chang, L., et al.
Publicado: (2016)

Early response predicts a sustained response to eluxadoline in patients with irritable bowel syndrome with diarrhoea in two Phase 3 studies
por: Chey, W. D., et al.
Publicado: (2017)

Gut microbiome composition and risk factors in a large cross-sectional IBS cohort
por: Agnello, Melissa, et al.
Publicado: (2020)

Diet or medication in primary care patients with IBS: the DOMINO study - a randomised trial supported by the Belgian Health Care Knowledge Centre (KCE Trials Programme) and the Rome Foundation Research Institute
por: Carbone, Florencia, et al.
Publicado: (2022)

Development of a new version of the Bristol Stool Form Scale: translation, content validity, face validity, and reliability of the Persian version
por: Shokouhi, Nasim, et al.
Publicado: (2022)

Double-blinded randomised placebo controlled trial of enterosgel (polymethylsiloxane polyhydrate) for the treatment of IBS with diarrhoea (IBS-D)
por: Howell, Carol Angela, et al.
Publicado: (2022)

Irritant-induced Asthma Caused by Aerotoxic Syndrome
por: Roig, Jorge, et al.
Publicado: (2021)

Managing vitamin D deficiency in inflammatory bowel disease
por: Nielsen, Ole Haagen, et al.
Publicado: (2019)

Dietary intakes in people with irritable bowel syndrome
por: Williams, Elizabeth A, et al.
Publicado: (2011)

Using best practice to create a pathway to improve management of irritable bowel syndrome: aiming for timely diagnosis, effective treatment and equitable care
por: Williams, Marianne, et al.
Publicado: (2016)

Inflammation decreases keratin level in ulcerative colitis; inadequate restoration associates with increased risk of colitis-associated cancer
por: Corfe, Bernard M, et al.
Publicado: (2015)

Health-related quality of life and depression among participants in the Sjögren’s International Collaborative Clinical Alliance registry
por: Chou, Annie, et al.
Publicado: (2017)

Effect of a plant sterol, fish oil and B vitamin combination on cardiovascular risk factors in hypercholesterolemic children and adolescents: a pilot study
por: Garaiova, Iveta, et al.
Publicado: (2013)

Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome
por: Jeppesen, P B, et al.
Publicado: (2011)

Mixed‐Methods Study Identifying Key Intervention Targets to Improve Participation in Daily Living Activities in Primary Sjögren's Syndrome Patients
por: Hackett, Katie L., et al.
Publicado: (2018)

Use of colony-based bacterial strain typing for tracking the fate of Lactobacillus strains during human consumption
por: Mahenthiralingam, Eshwar, et al.
Publicado: (2009)

Panenteric capsule endoscopy identifies proximal small bowel disease guiding upstaging and treatment intensification in Crohn's disease: A European multicentre observational cohort study
por: Tai, Foong Way D., et al.
Publicado: (2021)

Therapeutic Effect of Vitamin D Supplementation in a Pilot Study of Crohn's Patients
por: Yang, Linlin, et al.
Publicado: (2013)

A pilot feasibility trial of cognitive–behavioural therapy for insomnia in people with inflammatory bowel disease
por: Salwen-Deremer, Jessica K, et al.
Publicado: (2021)

A randomised cross-over trial in healthy adults indicating improved absorption of omega-3 fatty acids by pre-emulsification
por: Garaiova, Iveta, et al.
Publicado: (2007)

Subclinical bowel inflammation increases healthcare resources utilization and steroid use before diagnosis of inflammatory bowel disease
por: Rodríguez‐Lago, Iago, et al.
Publicado: (2022)

Changing paradigms in management of inflammatory bowel disease
por: Mao, Ren, et al.
Publicado: (2022)

Environmental risk factors for inflammatory bowel disease
por: Singh, Noreen, et al.
Publicado: (2022)

New endoscopic tools in inflammatory bowel disease
por: Nardone, Olga Maria, et al.
Publicado: (2022)

Can adjuncts to bowel preparation for colonoscopy improve patient experience and result in superior bowel cleanliness? A systematic review and meta-analysis
por: Kamran, Umair, et al.
Publicado: (2020)

Ultrasonography in inflammatory bowel disease – So far we are?
por: Christian, Maaser, et al.
Publicado: (2022)

Landscape of new drugs and targets in inflammatory bowel disease
por: Vieujean, Sophie, et al.
Publicado: (2022)

Is hypertension an extra‐intestinal manifestation of inflammatory bowel disease?
por: Burisch, Johan
Publicado: (2023)

Avoiding food avoidance in patients with inflammatory bowel disease
por: Godny, Lihi, et al.
Publicado: (2023)

Faecal metabolome and its determinants in inflammatory bowel disease
por: Vich Vila, Arnau, et al.
Publicado: (2023)

Sjögren’s and non-Sjögren’s sicca share a similar symptom burden but with a distinct symptom-associated proteomic signature
por: Pucino, Valentina, et al.
Publicado: (2022)

Physical Fitness in Adolescence and Subsequent Inflammatory Bowel Disease Risk
por: Melinder, Carren, et al.
Publicado: (2015)

Endoscopy and histology in inflammatory bowel diseases patients: Complementary or alternatives?
por: D'Amico, Ferdinando, et al.
Publicado: (2022)

Identifying and understanding disease burden in patients with inflammatory bowel disease
por: Christensen, Katrine Risager, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1c4oarajif36rkn138ie6419tu